Skip to main content
. 2020 May 9;7(6):ofaa164. doi: 10.1093/ofid/ofaa164

Table 3.

Outcomes of Infection Associated With Injection of Contaminated Methylprednisolone

Cure: Improvement or resolution of symptoms and/or signs compared with baseline, defined as the date on which the diagnosis was established, no clinical evidence of active infection, and off antifungal therapy for at least 3 months
Improved: Improvement or resolution of symptoms and/or signs compared with baseline; may have clinical evidence of active infection; may or may not be off antifungal therapy
Stable: Little or no improvement of symptoms and/or signs as compared with baseline; may have clinical evidence of infection; may or may not be off antifungal therapy
Progression: Worsening symptoms and/or signs of infection compared with baseline
Relapse: Recurrent symptoms and/or signs occurring off antifungal therapy and radiographic or laboratory evidence to support the diagnosis of relapse